1.00 / AMA PRA Category 1 Credit(s)TM 1.00 / CNE for Nurses
This activity is provided by Haymarket Medical Education (HME) for physician credit. This activity is jointly provided by Global Education Group and HME for nursing contact hours.
Supported by Ironwood Pharmaceuticals, Inc.
Gout is most often diagnosed and managed in the primary care setting, with referral to specialty care as required. Hyperuricemia underlies gout and has been linked to a host of potentially serious sequelae. However, despite a number of recent advances in gout management, many patients still do not achieve adequate control of serum uric acid levels. In addition, discordance between evidence-based guidelines from major medical organizations regarding the optimal treatment of gout has led to confusion and controversy.
To help bridge persistent practice gaps, this educational activity will feature an in-depth discussion of the potential effects of uncontrolled hyperuricemia. Strategies for managing hyperuricemia beyond acute gout attacks will be described. Available and emerging urate-lowering therapy will be discussed in detail. The faculty will review the importance of educating patients with gout about the potential effects of hyperuricemia and the importance of long-term adherence to help mitigate these effects.
Primary care and internal medicine clinicians (MDs/DOs, physician assistants [PAs], nurse practitioners [NPs] and nurses); rheumatologists.
After completing the activity, the participant should be better able to:
Describe the complications associated with uncontrolled hyperuricemia
Review markers for quality care in patients with gout
Discuss available and emerging options for urate-lowering therapy
Implement effective treatment in patients with hyperuricemia
Conflict Of Interest Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, Haymarket Medical Education (HME) and Global Education Group require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME and Global Education resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational activities.
Michael Pillinger, MD Chief of Rheumatology, VA NY Harbor Health Care System Director, Clinical and Translational Science Institute Education and Careers Unit New York University New York, NY
Dr. Pillinger is a consultant to Horizon Pharmaceuticals and Ironwood Pharmaceuticals, Inc.
Naomi Schlesinger, MD Professor of Medicine Chief, Division of Rheumatology Department of Medicine Rutgers – Robert Wood Johnson Medical School New Brunswick, NJ
Dr. Schlesinger receives grant/research support from AstraZeneca, is a consultant to BMS, Novartis, and Sobi, Inc., and receives honoraria from AstraZeneca, Celgene, Horizon, ProteoThera, Inc., and Pfizer.
Accredited Provider Disclosures
The planners, managers, and reviewers for this program reported the following financial relationships with commercial interests whose products or services may be related to the content of this CME activity:
HME planners, managers, and reviewers have no relevant financial relationships to disclose. Global Education Group planners: Ashley Marostica, RN, MSN, Lindsay Borvansky, and Liddy Knight have nothing to disclose.
Publishing Staff Disclosures
Susan Basilico and Krista Sierra have nothing to disclose in regard to commercial support.
AMA PRA Category 1 Credit(s)TM
Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Haymarket Medical Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Contact Hour(s)
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity for 1.00 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity. This activity is jointly provided by Global Education Group and Haymarket for ANCC credit.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. HME and Global Education Group do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Ironwood, Global Education Group, and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
In order to receive credit for this activity, the participant must complete the pre-activity questionnaire, post-test, and program evaluation. Participants must also score at least 70% on the post-test. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.